Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

IBM Acquires Bowstreet Inc.

Related Content

SEC Issues Proposal to Update Regulation of Transfer Agents

FDIC and OCC Issue Final Rule Defining “Unsafe or Unsound Practice” and Establishing Standards for Issuing Matters Requiring Attention

When the Safe Harbor Is Not Safe: Court of Chancery Weighs in on Amended Section 144 in Dodiya v. Franklin

SEC to Cease Responding to No-Action Requests on Rule 14a-8 Shareholder Proposal Exclusions

Treasury Proposes Rules Regarding the Issuance, Offering, and Sale of Payment Stablecoins

SEC Announces Formation of Specialized Unit Within Division of Enforcement to Combat Accounting and Financial Reporting Fraud

Federal Reserve Proposes Modernized Rules for Mutual Banking Organizations

SEC Division Issues Order Approving Nasdaq’s New $5 Million Market Value Continued Listing Requirement; Order Subsequently Stayed

Goodwin Strengthens Life Sciences and Public M&A Platform With Partner Ro Park

Goodwin Advises Merida Biosciences in up to $2.875 Billion Acquisition by Eli Lilly

Goodwin Earns Top Spot for Global M&A in H1 2026 League Tables

AstraZeneca May Keep Chasing Transformative M&A or Merger After Abandoned BMS Deal (Mergermarket)

Goodwin Advises AvalonBay on Completion of $70 Billion Merger With Equity Residential to Create Vivmark Residential, One of the Country’s Leading Real Estate Companies

Goodwin Advises Dynatrace on $915 Million Agreement to Acquire Arize

Goodwin Advises Thoma Bravo on $4 Billion Acquisition of Accelerant

New England Legal Awards Recognize Goodwin Partners Across Key Categories

Technology

Mergers & Acquisitions

Technology M&A